Takarazuka, Japan

Kaoru Kikuchi



Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Takarazuka, JP (1999 - 2008)
  • Hyogo, JP (2003 - 2008)

Company Filing History:


Years Active: 1999-2008

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kaoru Kikuchi: Innovator in Nerve Regeneration

Introduction

Kaoru Kikuchi is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of nerve regeneration, holding a total of 8 patents. His work focuses on developing innovative methods and compounds that promote nerve healing and regeneration.

Latest Patents

Kikuchi's latest patents include a screening method for agonists or antagonists of semaphorin 6C. This method determines the effect of a test compound on the interaction between semaphorin 6C and plexin-A1. The invention provides tools for screening and evaluates the connectivity of proteins involved in nerve regeneration. Another notable patent involves nerve regeneration promoters containing semaphorin inhibitors as active ingredients. This invention aims to provide remedies for neuropathic and neurodegenerative diseases by utilizing low-molecular weight compounds that inhibit semaphorin activity.

Career Highlights

Throughout his career, Kaoru Kikuchi has worked with notable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical and biotechnology sectors.

Collaborations

Kikuchi has collaborated with esteemed colleagues, including Toru Kimura and Kazuo Kumagai. These partnerships have enhanced his research and development efforts in the field of nerve regeneration.

Conclusion

Kaoru Kikuchi's innovative work in nerve regeneration and his numerous patents highlight his significant impact on medical science. His contributions continue to pave the way for advancements in treatments for nerve-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…